CSIMarket Company Name, Ticker, Industry, else..


Bicycle Therapeutics Plc  (BCYC)
Other Ticker:  
 

Bicycle Therapeutics Plc

BCYC's Fundamental analysis



Bicycle Therapeutics Plc's sales fell by -30.44 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 929

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Bicycle Therapeutics Plc net loss increased from $-49 millions, to $-52 millions in IV. Quarter 2024,

• More on BCYC's Growth


Bicycle Therapeutics Plc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.43 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.33.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.


• More on BCYC's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 578,279
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 13.61

Bicycle Therapeutics Plc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.43 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.33.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.

Bicycle Therapeutics Plc Price to Book Ratio is at 0.64 lower than Industry Avg. of 78.87. and higher than S&P 500 Avg. of 0.01

• More on BCYC's Valuation

•  Market Capitalization (Millions $) 505
•  Shares Outstanding (Millions) 58
•  Employees 61
•  Revenues (TTM) (Millions $) 35
•  Net Income (TTM) (Millions $) -169
•  Cash Flow (TTM) (Millions $) 353
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 578,279
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 13.61

•  Market Capitalization (Millions $) 505
•  Shares Outstanding (Millions) 58
•  Employees 61
•  Revenues (TTM) (Millions $) 35
•  Net Income (TTM) (Millions $) -169
•  Cash Flow (TTM) (Millions $) 353
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 13.81
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.2
•  Asset Turnover Ratio (TTM) 0.04
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com